{"sent_idx": "9", "frame_idx": "2", "ev": "The PHF and HAART arms did not differ significantly in the occurrence of AIDS-related illnesses over the study period of 24 months.", "icos": [["1", "PHF", "HAART", "occurrence of AIDS - related illnesses"]], "sample": "x"}
{"sent_idx": "10", "frame_idx": "3", "ev": "In the PHF-to-HAART arm, the rates of CD4 count and reduction in viral load were significant and comparable to that of the HAART group.", "icos": [["1", "HAART", "PHF - to - HAART", "rates of CD4 count and reduction in viral load"]], "sample": "x"}
{"sent_idx": "22", "frame_idx": "8", "ev": "The PHF and HAART arms did not differ significantly in the occurrence of AIDS-related illnesses over the study period of 24 months.", "icos": [["1", "PHF", "HAART", "occurrence of AIDS - related illnesses"]], "sample": "x"}
{"sent_idx": "23", "frame_idx": "9", "ev": "In the PHF-to-HAART arm, the rates of CD4 count and reduction in viral load were significant and comparable to that of the HAART group.", "icos": [["1", "HAART", "PHF - to - HAART", "rates of CD4 count and reduction in viral load"]], "sample": "x"}
{"sent_idx": "167", "frame_idx": "15", "ev": "The slow kinetics of the CD4 cell reduction in the PHF arm, 14.3 \u00b1 6.1 cells/\u03bcl lost per year (R2 = 0.029, P=0.021), contrasted that of the HAART and the difference between the two arms was statistically significant at all the time points (P<0.001) subsequent to the baseline.", "icos": [["0.9995322", "HAART", "highly active anti - retroviral therapy ( HAART )", "CD4 cell reduction"], ["0.99950445", "HAART", "HAART .", "CD4 cell reduction"], ["0.99949515", "HAART", "HAART", "CD4 cell reduction"], ["0.9994935", "HAART", "highly active antiretroviral treatment ( HAART )", "CD4 cell reduction"], ["0.9993926", "HAART", "FBP , FTP , FKC , FMC , FCK and FPB ,)", "CD4 cell reduction"]], "sample": "c"}
{"sent_idx": "185", "frame_idx": "19", "ev": "In contrast, in the PHF-to-HAART group, the reduction in the CD4 count became significant at 15 months (P=0.043) and thereafter, although fewer data points were available for this analysis.", "icos": [["0.9995933", "PHF - to - HAART", "PHF", "CD4 count"], ["0.99952126", "PHF - to - HAART", "PHF - to - HAART", "CD4 count"], ["0.99834454", "PHF - to - HAART", "HAART", "CD4 count"], ["0.9982986", "PHF - to - HAART", "HAART .", "CD4 count"], ["0.99819946", "PHF - to - HAART", "polyherbal formulation ( PHF )", "CD4 count"]], "sample": "c"}
{"sent_idx": "250", "frame_idx": "25", "ev": "The CD4 cell loss observed in the PHF and PHF-to-HAART arms in the present study, both in the absence of antiretroviral therapy was significantly smaller than that reported previously.", "icos": [["0.9996439", "PHF - to - HAART", "PHF", "CD4 cell loss"], ["0.99960285", "PHF - to - HAART", "PHF - to - HAART", "CD4 cell loss"], ["0.9988832", "PHF - to - HAART", "HAART .", "CD4 cell loss"], ["0.99855095", "PHF - to - HAART", "HAART", "CD4 cell loss"], ["0.99730575", "PHF - to - HAART", "highly active anti - retroviral therapy ( HAART )", "CD4 cell loss"]], "sample": "c"}
